Trials / Completed
CompletedNCT03426150
Casein Phosphopeptide--amorphous Calcium Phosphate on Human Enamel Subjected to in Vivo Acid Attacks
In Situ Effect of Casein Phosphopeptide--amorphous Calcium Phosphate on the Surface Microhardness of Human Enamel Subjected to in Vivo Acid Attacks
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
40 specimens were prepared from fresh-extracted human molars and further embedded using the acrylic resin. Specimens were randomly divided into 2 groups according to the treatment before in vivo erosion (n=20): CPP-ACP for 3 min (CPP-ACP group) and deionized water for 3 min (control group). 10 healthy volunteers were recruited and customized maxillary appliance containing 4 specimens (2 from CPP-ACP group and 2 from control group) was fabricated for each volunteer. Participants were instructed to drink 150 ml cola in 5 min using the gargling method after placing appliances intraorally for 2 h. The in vivo attacks were performed 4 X 5 min with 1-h interval daily over 7 d. The surface microhardness and surface microstructure of the specimens were evaluated at the baseline and after the treatment. The data were statistically analyzed using three-way ANOVA and post hoc tests. Data were considered statistically significant at a level of P \<0.05.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CPP-ACP | The surfaces of specimens were pretreated with CPP-ACP for 3 min |
| DRUG | Placebos | The surfaces of specimens were pretreated with deionized water for 3 min |
Timeline
- Start date
- 2015-12-25
- Primary completion
- 2017-10-25
- Completion
- 2018-02-05
- First posted
- 2018-02-08
- Last updated
- 2018-02-08
Source: ClinicalTrials.gov record NCT03426150. Inclusion in this directory is not an endorsement.